[Radioprogestins. Their clinical use].
It was obtained by synthesis a radioprogestin-iodine-131 and proved in two patients with hormono-dependent meningioma to progesterone with very good results in the scan of cerebral tumours localization; and in one patient in the treatment of this kind of tumour. No radiotoxicity or intolerance was present until today in six month of follow-up of this preliminary uses of radioprogestin in cerebral tumours hormono-dependent to progesterone; so it is proposed the use of this new radiopharmaco for the diagnosis and treatment of this tumours.